Antimicrobial resistance research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemic.


Journal

Journal of global antimicrobial resistance
ISSN: 2213-7173
Titre abrégé: J Glob Antimicrob Resist
Pays: Netherlands
ID NLM: 101622459

Informations de publication

Date de publication:
06 2021
Historique:
received: 15 01 2021
accepted: 16 02 2021
pubmed: 5 3 2021
medline: 24 6 2021
entrez: 4 3 2021
Statut: ppublish

Résumé

Antimicrobial resistance must be recognised as a global societal priority - even in the face of the worldwide challenge of the COVID-19 pandemic. COVID-19 has illustrated the vulnerability of our healthcare systems in co-managing multiple infectious disease threats as resources for monitoring and detecting, and conducting research on antimicrobial resistance have been compromised during the pandemic. The increased awareness of the importance of infectious diseases, clinical microbiology and infection control and lessons learnt during the COVID-19 pandemic should be exploited to ensure that emergence of future infectious disease threats, including those related to AMR, are minimised. Harnessing the public understanding of the relevance of infectious diseases towards the long-term pandemic of AMR could have major implications for promoting good practices about the control of AMR transmission.

Identifiants

pubmed: 33662647
pii: S2213-7165(21)00045-X
doi: 10.1016/j.jgar.2021.02.013
pmc: PMC7919515
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5-7

Subventions

Organisme : Medical Research Council
ID : MR/S004793/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S037640/1
Pays : United Kingdom

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Références

Int J Antimicrob Agents. 2020 Apr;55(4):105946
pubmed: 32199877
Anesth Analg. 2020 Jul;131(1):86-92
pubmed: 32243287
Travel Med Infect Dis. 2020 Sep - Oct;37:101878
pubmed: 32927051
Clin Microbiol Infect. 2020 Dec;26(12):1622-1629
pubmed: 32711058
Clin Microbiol Infect. 2021 Jan;27(1):83-88
pubmed: 32745596
Science. 2020 Jul 24;369(6502):413-422
pubmed: 32532802
Lancet Planet Health. 2018 Sep;2(9):e398-e405
pubmed: 30177008
Clin Infect Dis. 2020 Dec 3;71(9):2459-2468
pubmed: 32358954

Auteurs

Jesús Rodríguez-Baño (J)

Unidad Clínica de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospital Universitario Virgen Macarena, Seville, Spain; Departamento de Medicina, Universidad de Sevilla, Seville, Spain; Instituto de Biomedicina de Sevilla (IBiS), Seville, Spain; Red Española de Investigación en Patología Infecciosa (REIPI), Instituto de Salud Carlos III. Madrid, Spain.

Gian Maria Rossolini (GM)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; Clinical Microbiology and Virology Unit, Florence Careggi University Hospital, Florence, Italy.

Constance Schultsz (C)

Department of Global Health-AIGHD Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Evelina Tacconelli (E)

Division of Infectious Diseases, Department of Diagnostic and Public Health, University of Verona, Verona, Italy.

Srinivas Murthy (S)

BC Children's Hospital, University of British Columbia, Vancouver, Canada.

Norio Ohmagari (N)

Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.

Alison Holmes (A)

Department of Medicine, Faculty of Medicine, Imperial College London, London, UK.

Till Bachmann (T)

The University of Edinburgh, Edinburgh Medical School, Division of Infection and Pathway Medicine, The Chancellor's Building, Edinburgh, UK.

Herman Goossens (H)

Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.

Rafael Canton (R)

Servicio de Microbiología, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain; Red Española de Investigación en Patología Infecciosa (REIPI), Instituto de Salud Carlos III, Madrid, Spain.

Adam P Roberts (AP)

Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, UK.

Birgitta Henriques-Normark (B)

Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden; Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden.

Cornelius J Clancy (CJ)

University of Pittsburgh, 3550 Terrace St., Scaife Hall 867, Pittsburgh, PA, USA.

Benedikt Huttner (B)

Division of Infectious Diseases, Geneva University Hospitals, Faculty of Medicine, University of Geneva, Geneva, Switzerland.

Patriq Fagerstedt (P)

JPIAMR Secretariat, Swedish Research Council, Stockholm, Sweden.

Shawon Lahiri (S)

JPIAMR Secretariat, Swedish Research Council, Stockholm, Sweden.

Charu Kaushic (C)

Institute of Infection and Immunity, Canadian Institutes of Health Research, Canada; McMaster Immunology Research Center, Department Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.

Steven J Hoffman (SJ)

Global Strategy Lab, Dahdaleh Institute for Global Health Research, School of Global Health and Osgoode Hall Law School, York University, Toronto, Canada.

Margo Warren (M)

Access to Medicine Foundation, Naritaweg 227-A, 1043 CB, Amsterdam, The Netherlands.

Ghada Zoubiane (G)

International Centre for Antimicrobial Resistance Solutions (ICARS), Copenhagen, Denmark.

Sabiha Essack (S)

International Centre for Antimicrobial Resistance Solutions (ICARS), Copenhagen, Denmark; Antimicrobial Research Unit, University of KwaZulu-Natal, Durban, South Africa.

Ramanan Laxminarayan (R)

Center for Disease Dynamics, Economics & Policy, New Delhi, India.

Laura Plant (L)

Institute of Infection and Immunity, Canadian Institutes of Health Research, Canada. Electronic address: Laura.Plant@vr.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH